Logo
K

Kineta

30 employees

Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Immuno-oncology
Therapeutics
Chronic Pain
Biodefense
Neuroscience
Immunology
Medical Device
Virology
Lassa fever
Antivirals

Date founded

2008

Funding rounds raised

Total raised

$17M

from 8 investors over 8 rounds

K

Kineta raised $6M on April 20, 2023

Investors: Keiretsu Capital

K

Kineta raised $17M on June 1, 2021

Investors: CBI Co Ltd

K

Kineta raised $5M on May 5, 2020

Investors: Scott • Schlaepfer Family Foundation and Keiretsu Capital

K

Kineta raised $1.8M on August 6, 2019

Investors: Wellcome Trust

K

Kineta raised $45K on May 9, 2019

Investors: Keiretsu Capital and SFC Capital

K

Kineta raised $5M on September 11, 2017

Investors: Keiretsu Capital

FAQ